These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28206952)

  • 1. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.
    Lu PH; Chen MB; Liu YY; Wu MH; Li WT; Wei MX; Liu CY; Qin SK
    Oncotarget; 2017 Apr; 8(14):22800-22810. PubMed ID: 28206952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
    Lv H; Zhang Z; Wu X; Wang Y; Li C; Gong W; Gui L; Wang X
    PLoS One; 2016; 11(1):e0145195. PubMed ID: 26727592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blockage of Ras/ERK pathway augments the sensitivity of SphK1 inhibitor SKI II in human hepatoma HepG2 cells.
    Zhang C; He H; Zhang H; Yu D; Zhao W; Chen Y; Shao R
    Biochem Biophys Res Commun; 2013 Apr; 434(1):35-41. PubMed ID: 23545258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma.
    Zhang Z; Yan Z; Yuan Z; Sun Y; He H; Mai C
    Tumour Biol; 2015 Mar; 36(3):1503-9. PubMed ID: 25537088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ
    Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceramide production mediates cinobufotalin-induced growth inhibition and apoptosis in cultured hepatocellular carcinoma cells.
    Cheng L; Chen YZ; Peng Y; Yi N; Gu XS; Jin Y; Bai XM
    Tumour Biol; 2015 Aug; 36(8):5763-71. PubMed ID: 25724183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus X protein promotes human hepatoma cell growth via upregulation of transcription factor AP2α and sphingosine kinase 1.
    Lu ZP; Xiao ZL; Yang Z; Li J; Feng GX; Chen FQ; Li YH; Feng JY; Gao YE; Ye LH; Zhang XD
    Acta Pharmacol Sin; 2015 Oct; 36(10):1228-36. PubMed ID: 26073327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-hepatocellular carcinoma cell activity by a novel mTOR kinase inhibitor CZ415.
    Zhang W; Chen B; Zhang Y; Li K; Hao K; Jiang L; Wang Y; Mou X; Xu X; Wang Z
    Biochem Biophys Res Commun; 2017 Jun; 487(3):494-499. PubMed ID: 28366631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro.
    Yao C; Wu S; Li D; Ding H; Wang Z; Yang Y; Yan S; Gu Z
    Mol Oncol; 2012 Aug; 6(4):392-404. PubMed ID: 22583777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma.
    Bao M; Chen Z; Xu Y; Zhao Y; Zha R; Huang S; Liu L; Chen T; Li J; Tu H; He X
    Liver Int; 2012 Feb; 32(2):331-8. PubMed ID: 22098666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor.
    He J; Wang Y; Duan F; Jiang H; Chen MF; Tang SY
    Planta Med; 2010 Nov; 76(16):1834-9. PubMed ID: 20560114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C6 ceramide sensitizes the anti-hepatocellular carcinoma (HCC) activity by AZD-8055, a novel mTORC1/2 dual inhibitor.
    Liu M; Gu P; Guo W; Fan X
    Tumour Biol; 2016 Aug; 37(8):11039-48. PubMed ID: 26897748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.
    Xie Z; Wang J; Liu M; Chen D; Qiu C; Sun K
    PLoS One; 2017; 12(3):e0173252. PubMed ID: 28334043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.
    Stefanovic M; Tutusaus A; Martinez-Nieto GA; Bárcena C; de Gregorio E; Moutinho C; Barbero-Camps E; Villanueva A; Colell A; Marí M; García-Ruiz C; Fernandez-Checa JC; Morales A
    Oncotarget; 2016 Feb; 7(7):8253-67. PubMed ID: 26811497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furowanin A Exhibits Antiproliferative and Pro-Apoptotic Activities by Targeting Sphingosine Kinase 1 in Osteosarcoma.
    Wei K; Sun H; Chen X; Chen Q; Li Y; Wu H
    Anat Rec (Hoboken); 2019 Nov; 302(11):1941-1949. PubMed ID: 31197942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo.
    Funaki M; Kitabayashi J; Shimakami T; Nagata N; Sakai Y; Takegoshi K; Okada H; Murai K; Shirasaki T; Oyama T; Yamashita T; Ota T; Takuwa Y; Honda M; Kaneko S
    Sci Rep; 2017 Dec; 7(1):16978. PubMed ID: 29208982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation.
    Tao H; Liu M; Wang Y; Luo S; Xu Y; Ye B; Zheng L; Meng K; Li L
    Front Immunol; 2021; 12():609295. PubMed ID: 33717093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.